New Delhi: The Indian Council of Medical Research (ICMR) on Tuesday said that it will continue with its study on the use of hydroxychloroquine for prevention from covid-19 infection despite safety concerns around the drug leading to a temporary suspension of a global trial. “What we found from observational studies and from case-control studies is that it may be working, and we also found that there were no major side-effects except nausea, vomiting and some palpitations.
That was from the Indian Pharmacopoeia Commission," Balram Bhargava, health research secretary and ICMR director general, said at a press conference.
Read more on livemint.com